{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:17:11Z","timestamp":1794352631431,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFA1205704"],"award-info":[{"award-number":["2022YFA1205704"]}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["YQ2023H015"],"award-info":[{"award-number":["YQ2023H015"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for the Provincial Universities of Heilongjiang","award":["2022KYYWF-0298"],"award-info":[{"award-number":["2022KYYWF-0298"]}]},{"name":"Research Fund of the Fourth Affiliated Hospital of Harbin Medical University","award":["HYDSYRCYJ02"],"award-info":[{"award-number":["HYDSYRCYJ02"]}]},{"name":"Research Fund of Chongqing Key Laboratory of Development and Utilization of Genuine Medicine in the Three Gorges Reservoir Area","award":["KFKT2022011"],"award-info":[{"award-number":["KFKT2022011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-025-00814-7","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:25:21Z","timestamp":1761629121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Circular RNA circSLC39A10 promotes prostate cancer progression by activating Wnt signaling via the miR-936\/PROX1\/\u03b2-catenin axis"],"prefix":"10.1186","volume":"30","author":[{"given":"Kailai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanlong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9644-5025","authenticated-orcid":false,"given":"Yakun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"1","key":"814_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"814_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai M, Song XL, Li XA, Chen M, Guo J, Yang DH, et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist Updat. 2023;68:100962.","journal-title":"Drug Resist Updat"},{"issue":"5","key":"814_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/pros.24664","volume":"84","author":"I de Kouchkovsky","year":"2024","unstructured":"de Kouchkovsky I, Chan E, Schloss C, Poehlein C, Aggarwal R. Diagnosis and management of neuroendocrine prostate cancer. Prostate. 2024;84(5):426\u201340.","journal-title":"Prostate"},{"issue":"9","key":"814_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24(9):597\u2013613.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"814_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172.","journal-title":"Mol Cancer"},{"issue":"38","key":"814_CR6","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","volume":"42","author":"G Pisignano","year":"2023","unstructured":"Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circRNAs in cancer. Oncogene. 2023;42(38):2783\u2013800.","journal-title":"Oncogene"},{"issue":"3","key":"814_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188\u2013206.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"814_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1158\/0008-5472.CAN-23-1899","volume":"84","author":"Y Xu","year":"2024","unstructured":"Xu Y, Li X, Zhang S, Tang M, Yu R, Liao X, et al. CircMMP2(6,7) cooperates with \u03b2-catenin and PRMT5 to disrupt bone homeostasis and promote breast cancer bone metastasis. Cancer Res. 2024;84(2):328\u201343.","journal-title":"Cancer Res"},{"issue":"30","key":"814_CR9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220296120","volume":"120","author":"B Liu","year":"2023","unstructured":"Liu B, Shen H, He J, Jin B, Tian Y, Li W, et al. Cytoskeleton remodeling mediated by circRNA-YBX1 phase separation suppresses the metastasis of liver cancer. Proc Natl Acad Sci U S A. 2023;120(30):e2220296120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"814_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2021.10.011","volume":"524","author":"V Mugoni","year":"2022","unstructured":"Mugoni V, Ciani Y, Nardella C, Demichelis F. Circulating RNAs in prostate cancer patients. Cancer Lett. 2022;524:57\u201369.","journal-title":"Cancer Lett"},{"issue":"1","key":"814_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-023-01766-2","volume":"22","author":"ZH Zhang","year":"2023","unstructured":"Zhang ZH, Wang Y, Zhang Y, Zheng SF, Feng T, Tian X, et al. The function and mechanisms of action of circular RNAs in urologic cancer. Mol Cancer. 2023;22(1):61.","journal-title":"Mol Cancer"},{"issue":"1","key":"814_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, et al. Wnt\/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6(1):307.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"814_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrurol.2017.144","volume":"14","author":"V Murillo-Garz\u00f3n","year":"2017","unstructured":"Murillo-Garz\u00f3n V, Kypta R. WNT signalling in prostate cancer. Nat Rev Urol. 2017;14(11):683\u201396.","journal-title":"Nat Rev Urol"},{"key":"814_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175781","volume":"951","author":"A Taheriazam","year":"2023","unstructured":"Taheriazam A, Bayanzadeh SD, Heydari Farahani M, Mojtabavi S, Zandieh MA, Gholami S, et al. Non-coding RNA-based therapeutics in cancer therapy: an emphasis on Wnt\/\u03b2-catenin control. Eur J Pharmacol. 2023;951:175781.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"814_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869-81.e13.","journal-title":"Cell"},{"issue":"1","key":"814_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13046-021-02058-7","volume":"40","author":"Y Luo","year":"2021","unstructured":"Luo Y, Vlaeminck-Guillem V, Baron S, Dallel S, Zhang CX, Le Romancer M. MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and \u03b2-catenin. J Exp Clin Cancer Res. 2021;40(1):270.","journal-title":"J Exp Clin Cancer Res"},{"issue":"32","key":"814_CR17","doi-asserted-by":"publisher","first-page":"11786","DOI":"10.1073\/pnas.1323557111","volume":"111","author":"S Hojyo","year":"2014","unstructured":"Hojyo S, Miyai T, Fujishiro H, Kawamura M, Yasuda T, Hijikata A, et al. Zinc transporter SLC39A10\/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength. Proc Natl Acad Sci U S A. 2014;111(32):11786\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"814_CR18","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/s12276-023-01062-5","volume":"55","author":"X Ren","year":"2023","unstructured":"Ren X, Feng C, Wang Y, Chen P, Wang S, Wang J, et al. SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK\/ERK and PI3K\/AKT pathways. Exp Mol Med. 2023;55(8):1757\u201369.","journal-title":"Exp Mol Med"},{"key":"814_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2147\/JHC.S320326","volume":"8","author":"Z Ma","year":"2021","unstructured":"Ma Z, Li Z, Wang S, Zhou Q, Ma Z, Liu C, et al. SLC39A10 upregulation predicts poor prognosis, promotes proliferation and migration, and correlates with immune infiltration in hepatocellular carcinoma. J Hepatocell Carcinoma. 2021;8:899\u2013912.","journal-title":"J Hepatocell Carcinoma"},{"issue":"5","key":"814_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/pros.21455","volume":"72","author":"T Naiki","year":"2012","unstructured":"Naiki T, Asamoto M, Toyoda-Hokaiwado N, Naiki-Ito A, Tozawa K, Kohri K, et al. Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice. Prostate. 2012;72(5):533\u201341.","journal-title":"Prostate"},{"issue":"11","key":"814_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36(11):1461\u201373.","journal-title":"Oncogene"},{"issue":"1","key":"814_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165.","journal-title":"J Hematol Oncol"},{"key":"814_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/978-3-030-32656-2_16","volume":"1210","author":"Y Yeh","year":"2019","unstructured":"Yeh Y, Guo Q, Connelly Z, Cheng S, Yang S, Prieto-Dominguez N, et al. Wnt\/beta-catenin signaling and prostate cancer therapy resistance. Adv Exp Med Biol. 2019;1210:351\u201378.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"814_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mc.22292","volume":"55","author":"J Xu","year":"2016","unstructured":"Xu J, Chen Y, Huo D, Khramtsov A, Khramtsova G, Zhang C, et al. \u03b2-catenin regulates c-Myc and CDKN1A expression in breast cancer cells. Mol Carcinog. 2016;55(5):431\u20139.","journal-title":"Mol Carcinog"},{"issue":"8","key":"814_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tcb.2010.05.002","volume":"20","author":"G Davidson","year":"2010","unstructured":"Davidson G, Niehrs C. Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol. 2010;20(8):453\u201360.","journal-title":"Trends Cell Biol"},{"issue":"48","key":"814_CR26","doi-asserted-by":"publisher","first-page":"19204","DOI":"10.1073\/pnas.1108977108","volume":"108","author":"E S\u00e1nchez-Till\u00f3","year":"2011","unstructured":"S\u00e1nchez-Till\u00f3 E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A. \u03b2-catenin\/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci U S A. 2011;108(48):19204\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"814_CR27","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.1038\/s41598-022-20777-5","volume":"12","author":"S Edachery","year":"2022","unstructured":"Edachery S, Patil P, Mohan R, Aradhya B, Shetty J, Kabekkodu SP, et al. Loss of miR-936 leads to acquisition of androgen-independent metastatic phenotype in prostate cancer. Sci Rep. 2022;12(1):17070.","journal-title":"Sci Rep"},{"issue":"1","key":"814_CR28","doi-asserted-by":"publisher","first-page":"14189","DOI":"10.1038\/s41598-018-32635-4","volume":"8","author":"R Zhang","year":"2018","unstructured":"Zhang R, Jing Y, Zhang H, Niu Y, Liu C, Wang J, et al. Comprehensive evolutionary analysis of the major RNA-induced silencing complex members. Sci Rep. 2018;8(1):14189.","journal-title":"Sci Rep"},{"key":"814_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101712","author":"C Catalanotto","year":"2016","unstructured":"Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci. 2016. https:\/\/doi.org\/10.3390\/ijms17101712.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"814_CR30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1101\/gad.1859310","volume":"24","author":"RS Srinivasan","year":"2010","unstructured":"Srinivasan RS, Geng X, Yang Y, Wang Y, Mukatira S, Studer M, et al. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev. 2010;24(7):696\u2013707.","journal-title":"Genes Dev"},{"issue":"3","key":"814_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4161\/cbt.23293","volume":"14","author":"TM Chang","year":"2013","unstructured":"Chang TM, Hung WC. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype. Cancer Biol Ther. 2013;14(3):222\u20139.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"814_CR32","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.7150\/ijbs.68960","volume":"18","author":"L Zhu","year":"2022","unstructured":"Zhu L, Tian Q, Gao H, Wu K, Wang B, Ge G, et al. PROX1 promotes breast cancer invasion and metastasis through WNT\/\u03b2-catenin pathway via interacting with hnRNPK. Int J Biol Sci. 2022;18(5):2032\u201346.","journal-title":"Int J Biol Sci"},{"key":"814_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217068","volume":"597","author":"C Liu","year":"2024","unstructured":"Liu C, Chen J, Cong Y, Chen K, Li H, He Q, et al. PROX1 drives neuroendocrine plasticity and liver metastases in prostate cancer. Cancer Lett. 2024;597:217068.","journal-title":"Cancer Lett"},{"issue":"44","key":"814_CR34","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1038\/onc.2015.7","volume":"34","author":"Y Liu","year":"2015","unstructured":"Liu Y, Ye X, Zhang JB, Ouyang H, Shen Z, Wu Y, et al. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing \u03b2-catenin expression and nuclear translocation. Oncogene. 2015;34(44):5524\u201335.","journal-title":"Oncogene"},{"issue":"26","key":"814_CR35","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/onc.2015.401","volume":"35","author":"EJ Yu","year":"2016","unstructured":"Yu EJ, Kim SH, Kim HJ, Heo K, Ou CY, Stallcup MR, et al. Positive regulation of \u03b2-catenin-PROX1 signaling axis by DBC1 in colon cancer progression. Oncogene. 2016;35(26):3410\u20138.","journal-title":"Oncogene"},{"issue":"1","key":"814_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-019-1002-6","volume":"18","author":"M Su","year":"2019","unstructured":"Su M, Xiao Y, Ma J, Tang Y, Tian B, Zhang Y, et al. Circular RNAs in cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers. Mol Cancer. 2019;18(1):90.","journal-title":"Mol Cancer"},{"key":"814_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.644397","volume":"9","author":"T Ding","year":"2021","unstructured":"Ding T, Zhu Y, Jin H, Zhang P, Guo J, Zheng J. Circular RNA circ_0057558 controls prostate cancer cell proliferation through regulating miR-206\/USP33\/c-Myc axis. Front Cell Dev Biol. 2021;9:644397.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"814_CR38","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41419-021-03743-3","volume":"12","author":"L Verduci","year":"2021","unstructured":"Verduci L, Tarcitano E, Strano S, Yarden Y, Blandino G. CircRNAs: role in human diseases and potential use as biomarkers. Cell Death Dis. 2021;12(5):468.","journal-title":"Cell Death Dis"},{"issue":"6","key":"814_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","volume":"38","author":"C Diener","year":"2022","unstructured":"Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 2022;38(6):613\u201326.","journal-title":"Trends Genet"},{"key":"814_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fonc.2020.00060","volume":"10","author":"XJ Lin","year":"2020","unstructured":"Lin XJ, Liu H, Li P, Wang HF, Yang AK, Di JM, et al. Mir-936 suppresses cell proliferation, invasion, and drug resistance of laryngeal squamous cell carcinoma and targets GPR78. Front Oncol. 2020;10:60.","journal-title":"Front Oncol"},{"key":"814_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12935-020-01399-1","volume":"20","author":"S Ding","year":"2020","unstructured":"Ding S, Zhang G, Gao Y, Chen S, Cao C. Circular RNA hsa_circ_0005909 modulates osteosarcoma progression via the miR-936\/HMGB1 axis. Cancer Cell Int. 2020;20:305.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"814_CR42","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1080\/21655979.2021.1932221","volume":"12","author":"D Zhou","year":"2021","unstructured":"Zhou D, Lin X, Wang P, Yang Y, Zheng J, Zhou D. Circular RNA circ_0001162 promotes cell proliferation and invasion of glioma via the miR-936\/ERBB4 axis. Bioengineered. 2021;12(1):2106\u201318.","journal-title":"Bioengineered"},{"issue":"2","key":"814_CR43","first-page":"58","volume":"29","author":"X Huang","year":"2023","unstructured":"Huang X, Wang Y, Chen M, Li G. MiR-936 targets GPR78 and regulates chemotherapy resistance in non-small cell lung cancer by activating the Galphaq Rho GTPase pathway. Altern Ther Health Med. 2023;29(2):58\u201363.","journal-title":"Altern Ther Health Med"},{"issue":"2","key":"814_CR44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/kjm2.12304","volume":"37","author":"S Liu","year":"2021","unstructured":"Liu S, Gong Y, Xu XD, Shen H, Gao S, Bao HD, et al. Microrna-936\/ERBB4\/Akt axis exhibits anticancer properties of gastric cancer through inhibition of cell proliferation, migration, and invasion. Kaohsiung J Med Sci. 2021;37(2):111\u201320.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"814_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-018-0877-y","volume":"17","author":"X Cui","year":"2018","unstructured":"Cui X, Wang J, Guo Z, Li M, Li M, Liu S, et al. Emerging function and potential diagnostic value of circular RNAs in cancer. Mol Cancer. 2018;17(1):123.","journal-title":"Mol Cancer"},{"issue":"1","key":"814_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17(1):46.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"814_CR47","first-page":"1827","volume":"52","author":"Y Luo","year":"2018","unstructured":"Luo Y, Li M, Zuo X, Basourakos SP, Zhang J, Zhao J, et al. \u03b2-catenin nuclear translocation induced by HIF-1\u03b1 overexpression leads to the radioresistance of prostate cancer. Int J Oncol. 2018;52(6):1827\u201340.","journal-title":"Int J Oncol"}],"container-title":["Cellular & Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00814-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00814-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00814-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:03:34Z","timestamp":1761674614000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00814-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["814"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00814-7","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human subject investigations received ethical clearance from the Fourth Affiliated Hospital of Harbin Medical University Ethics Committee (Approval 2021-WZYSLLSC-29) on 29 December 2021, adhering to the principles of the Declaration of Helsinki (1964) and subsequent amendments. Written informed consent was secured from all participants. Animal experimentation complied with NIH Laboratory Animal Guidelines (Publication 85\u201323, 1985 revision) and was authorized by Harbin Medical University\u2019s Animal Ethics Committee (2024-DWSYLLC2-02) on 2 February 2024. The ethics committee follows the guidelines of the International Council for Laboratory Animal Science (ICLAS) to ensure the ethical compliance of the experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The contributors confirm that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}